Literature DB >> 14593599

Association of mannose-binding lectin polymorphisms with sepsis and fatal outcome, in patients with systemic inflammatory response syndrome.

Peter Garred1, Jens J Strøm, Lars Quist, Ellen Taaning, Hans O Madsen.   

Abstract

Genetic factors may predispose critically ill patients to increased risk of developing sepsis. Mannose-binding lectin (MBL) is an important factor in innate immune defense. We investigated whether MBL gene polymorphisms causing low levels of MBL are associated with the development and progression of sepsis in adult patients in intensive care units. In 272 prospectively monitored patients with systemic inflammatory response syndrome, different MBL genotypes were compared, with respect to microbiology, sepsis development, and survival. The presence of MBL variant alleles was associated with the development of sepsis, severe sepsis, and septic shock. An increased risk of fatal outcome was observed in patients carrying variant alleles. These data show that MBL insufficiency plays an important role in the susceptibility of critically ill patients to the development and progression of sepsis and confers a substantial risk of fatal outcome.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14593599     DOI: 10.1086/379044

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  62 in total

1.  Mannose-binding lectin deficiency provides a genetic basis for the use of SIRS/sepsis definitions in critically ill patients.

Authors:  Joseph A Carcillo
Journal:  Intensive Care Med       Date:  2004-05-06       Impact factor: 17.440

2.  Association between mannose-binding lectin deficiency and septic shock following acute pyelonephritis due to Escherichia coli.

Authors:  Alex Smithson; Ana Muñoz; Belen Suarez; Sara Maria Soto; Rafael Perello; Alex Soriano; Jose Antonio Martinez; Jordi Vila; Juan Pablo Horcajada; Jose Mensa; Francisco Lozano
Journal:  Clin Vaccine Immunol       Date:  2007-01-03

3.  Mannose-binding lectin deficiency influences innate and antigen-presenting functions of blood myeloid dendritic cells.

Authors:  Melinda M Dean; Robert L Flower; Damon P Eisen; Robyn M Minchinton; Derek N J Hart; Slavica Vuckovic
Journal:  Immunology       Date:  2010-11-23       Impact factor: 7.397

Review 4.  Recent advances in genetic predisposition to clinical acute lung injury.

Authors:  Li Gao; Kathleen C Barnes
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-02-13       Impact factor: 5.464

5.  Low mannose-binding lectin (MBL) levels in neonates with pneumonia and sepsis.

Authors:  F N J Frakking; N Brouwer; N K A van Eijkelenburg; M P Merkus; T W Kuijpers; M Offringa; K M Dolman
Journal:  Clin Exp Immunol       Date:  2007-08-17       Impact factor: 4.330

6.  Interleukin-10 polymorphism in position -1082 and acute respiratory distress syndrome.

Authors:  M N Gong; B T Thompson; P L Williams; W Zhou; M Z Wang; L Pothier; D C Christiani
Journal:  Eur Respir J       Date:  2006-04       Impact factor: 16.671

7.  Involvement of the lectin pathway of complement activation in antimicrobial immune defense during experimental septic peritonitis.

Authors:  Michaela Windbichler; Bernd Echtenacher; Thomas Hehlgans; Jens C Jensenius; Wilhelm Schwaeble; Daniela N Männel
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

Review 8.  Genetic epidemiology of acute respiratory distress syndrome: implications for future prevention and treatment.

Authors:  Michelle Ng Gong
Journal:  Clin Chest Med       Date:  2006-12       Impact factor: 2.878

Review 9.  Bench-to-bedside review: Association of genetic variation with sepsis.

Authors:  Ainsley M Sutherland; Keith R Walley
Journal:  Crit Care       Date:  2009-04-29       Impact factor: 9.097

10.  Mannose-binding lectin genotypes: lack of association with susceptibility to thoracic empyema.

Authors:  Stephen J Chapman; Fredrik O Vannberg; Chiea C Khor; Anna Rautanen; Nicholas A Maskell; Christopher W H Davies; Catrin E Moore; Nicholas P Day; Derrick W Crook; Robert J O Davies; Adrian V S Hill
Journal:  BMC Med Genet       Date:  2010-01-15       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.